Amigula Incorporated -- The World's First Publicly Traded Marijuana Company

Vermont Lawmakers Vote to Allow Doctors to Study Medical Marijuana


NEW YORK, April 12, 2004 (PRIMEZONE) -- Amigula Incorporated (Other OTC:AMJL) the Worlds First Publicly traded Medical Marijuana Company announced today that the company intends to support research on medicinal marijuana and sponsor large-scale clinical trials.

California is the only state to legalize the use of marijuana as a medicine. Recently the State of California set up a fund to pay for research to discover the legitimacy of marijuana and its effectiveness in pain relief.

Warren Eugene - President of Amigula Incorporated states "researchers are an important component of our business model and company plans."

Mr. Eugene commented that last week, Vermont lawmakers voted to allow doctors to study medical marijuana. To end the controversy, marijuana experts say the substance needs to stand the same tests as any other medication.

"Preliminary reports indicate that some of the molecular structure - (cannabides) - in marijuana may be effective for a number of conditions.

Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward- looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing and access funds from our existing financing arrangements that will allow us to continue our current and future operations. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events.


Contact Data